SEC Form 4 · accession 0000899243-18-008417
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan G Drachman
Officer — See Remarks
Period of report
Mar 20, 2018
Accepted (ET)
Mar 22, 2018 · 9:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to buy)F1 | $34.20 | Mar 20, 2018 | A | 10,526 | A | — | May 9, 2026 | Common Stock | 10,526 | 10,526 | D |
Explanation of responses
- F1On May 9, 2016, the reporting person was granted an option to purchase 10,526 options of common stock. The performance criteria for this grant were met as of March 20, 2018 and the option shall vest in four (4) equal tranches on the first, second, third and fourth anniversaries of March 20, 2018 subject to continuous service with the Company as of each vesting date.
Remarks
CMO & EVP, Research & Development